We show that cCK-18 could also be a useful diagnostic biomarker that distinguishes IPF from chronic HP and NSIP, independent of age, gender, smoking, disease severity, and other baseline variables. This evidence concerns the gene CCK and idiopathic pulmonary fibrosis.